Home>Topics>Companies>Sanofi S.A.

Sanofi S.A.

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Actavis, Sanofi among bidders for Omega Pharma - Bloomberg

    Headlines

    Mon, 20 Oct 2014

    Oct 20 (Reuters) - Generic drugmaker Actavis Plc and France's Sanofi SA are among the suitors for privately held Omega Pharma NV, Bloomberg reported, citing people familiar with the matter.

  2. Dupilumab dermatitis trial underway

    Headlines

    Mon, 20 Oct 2014

    Regeneron Pharmaceuticals (NASDAQ: REGN ) and Sanofi (NYSE: SNY ) ( OTCQB:SNYNF ) initiate a Phase 3 clinical trial ..... VelocImmune technology and is being co-developed with Sanofi . Dermatitis-related tickers: (NYSE: VRX ) (NASDAQ

  3. Sanofi , Regeneron start Phase 3 trial of dupilumab in eczema

    Headlines

    Mon, 20 Oct 2014

    PARIS, Oct 20 (Reuters) - French drugmaker Sanofi and its U.S. partner Regeneron said on Monday they had started a Phase III clinical study of their experimental drug dupilumab in patients with atopic dermatitis.

  4. Amgen sues Sanofi and Regeneron

    Headlines

    Fri, 17 Oct 2014

    suit in the U.S. District Court of Delaware against Sanofi (NYSE: SNY ) ( OTCQB:SNYNF ) and Regeneron Pharmaceuticals (NASDAQ ..... injunction to prevent the manufacture, use and sale of Sanofi and Regeneron's PCSK9 inhibitor alirocumab . Amgen

  5. The State Of MannKind

    Headlines

    Tue, 14 Oct 2014

    financial prospects are as bright now as they've ever been, given both the FDA-approved product and the signing of Sanofi (NYSE: SNY ) Complete Story »

  6. Sanofi's Rotavirus vaccine enters late-stage trials

    Headlines

    Tue, 14 Oct 2014

    PARIS, Oct 14 (Reuters) - French drugmaker Sanofi said on Tuesday an investigational vaccine designed by its Shantha Biotechnics unit to protect young children from severe diarrhoea had entered late-stage clinical trials in India.

  7. 401 K contribution

    Commentary

    Mon, 13 Oct 2014

    Market Fund;Capital 2.28 Samsung Electronics Co Ltd 1.45 Tesco PLC 1.21 Nestle SA 1.10 Talisman Energy Inc 1.08 Sanofi SA 0.94 Ryanair Holdings PLC 0.88 Naspers Ltd 0.86 Schlumberger NV 0.84 Diversified Real Return- 10% TOP HOLDINGS

  8. MannKind: A Very Favorable Risk/Reward Profile

    Headlines

    Wed, 8 Oct 2014

    27th and a partnership with French pharmaceutical company Sanofi (NYSE: SNY ) to market and sell Afrezza. SNY has experience in the diabetes market with its blockbuster

  9. Sanofi tells U.S. authorities about bribery allegations

    Headlines

    Tue, 7 Oct 2014

    that face bribery claims in the Mideast and Africa, Sanofi (NYSE: SNY ) has informed the DOJ and SEC about allegations of improper ..... wherever we do business," says a company spokesman. Sanofi has hired New York law firm Weil Gotshal & Manges to

  10. Sanofi says told U.S. about bribery claims in Africa, Mideast

    Headlines

    Mon, 6 Oct 2014

    PARIS, Oct 7 (Reuters) - French drugmaker Sanofi said it had informed U.S. authorities of allegations of improper payments by its employees to healthcare professionals in East

« Prev12345Next »
Content Partners